Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

Question 2

How does APC8015F compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects might I experience from this immunotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses while I'm in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) clinical trial (NCT00849290). Contact the study team or your healthcare provider for specific answers.

What this study is about